Clinical Trial Update: Effect of Ketosteril on Sarcopenia in Patients With Chronic Kidney Disease [Phase 3]

View source ↗

Summary

Phase 3 clinical trial is evaluating Ketosteril for sarcopenia in patients with chronic kidney disease. Recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Sarcopenia

Drugs mentioned

• Ketosteril (ketosteril)

Snippet

Sponsor: Huashan Hospital | Conditions: Chronic Kidney Disease, Sarcopenia | Phase 3 | Status: RECRUITING